insights_auto
Prečo akcie DRUG klesli 4,91%?
Preskúmať podrobnejšiechevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
71,00 CAD
arrow_downward
-4,91%(-3,67) 1 d.
14. 10., 16:00:00 GMT-4 · CAD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre DRUG…
Otvoriť
72,00 CAD
Vysoká
75,77 CAD
Nízka
71,00 CAD
Trh. kap.
700,35 mil.
Priem. obj.
848,00
Objem
708,00
Max. za 52 týž.
170,00 CAD
Min. za 52 týž.
68,02 CAD
Výnosy na akciu
-2,90 CAD
Počet zamestnancov
26
Otvoriť
72,00 CAD
Vysoká
75,77 CAD
Nízka
71,00 CAD
Trh. kap.
700,35 mil.
Priem. obj.
848,00
Objem
708,00
Max. za 52 týž.
170,00 CAD
Min. za 52 týž.
68,02 CAD
Výnosy na akciu
-2,90 CAD
Počet zamestnancov
26
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
MarketBeat
·
pred 16 hodinami
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages
Profil
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Informácie o subjekte Bright Minds Biosciences Inc